Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

Tamoxifen citrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for tamoxifen citrate and what is the scope of tamoxifen citrate patent protection?

Tamoxifen citrate
is the generic ingredient in three branded drugs marketed by Teva, Midatech Pharma Us, Roxane, Actavis Labs Fl Inc, Mylan, Pharmachemie, Ivax Sub Teva Pharms, Mayne Pharma, Astrazeneca, Apotex, and Aegis Pharms, and is included in thirteen NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Tamoxifen citrate has six patent family members in seven countries.

There are sixteen drug master file entries for tamoxifen citrate. Twelve suppliers are listed for this compound.

Summary for Generic Name: tamoxifen citrate

Drug Master File Entries: see list16
Suppliers / Packagers: see list12
Bulk Api Vendors: see list47
Clinical Trials: see list365
Patent Applications: see list7,235
Therapeutic Class:Antineoplastics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:tamoxifen citrate at DailyMed

Pharmacology for Ingredient: tamoxifen citrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms
tamoxifen citrate
TABLET;ORAL075740-001Feb 20, 2003DISCNNoNo► Subscribe► Subscribe
Midatech Pharma Us
tamoxifen citrate
SOLUTION;ORAL021807-001Oct 29, 2005RXNoNo6,127,425► SubscribeY ► Subscribe
Actavis Labs Fl Inc
tamoxifen citrate
TABLET;ORAL076179-002Feb 20, 2003DISCNNoNo► Subscribe► Subscribe
tamoxifen citrate
TABLET;ORAL017970-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
tamoxifen citrate
TABLET;ORAL074732-002Feb 20, 2003ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus